What If Users Set Drug Prices?

Shifting Sands on Drug Pricing

What if health care insurers and payers set the price they would pay for drugs for their clients based on their value calculations? Until this past year such an occurrence seemed impossible or improbable. Short of a branded drug being genericized, patients had no recourse but to pay the company set prices. Some patients who could access drugs outside the U.S. or bought drugs online are able to get a lower price but also risk getting ineffective drugs.

What will pharma companies do in reaction to all the talk of others setting their prices? This will certainly happen in some form in the high priced cancer drug arena based on the momentum underway and public opinion supporting a change. What do you think?

Upcoming Life Science Events in the Bay Area The Week of July 20, 2015

• Bio2Device Group, Tuesday Morning, July 21, 2015, Topic: “Dye-less or OCT Angiography for Diagnosis and Management of Ocular Diseases;” Speaker: Utkarsh Sharma, Project Team Leader / Staff Scientist, Carl Zeiss Meditec
• BioScience Forum, Wednesday Evening, July 22, 2015; Topic: “Addressing the Challenges of Innovation Through Proactive Collaboration and Investment;”Speaker: Thorsten Melcher, Ph.D., Senior Director, New Ventures, Johnson & Johnson Innovation

You can download complete details for the above and other meetings through December by right clicking on Audreys Picks July 19, 2015.

Hope you are enjoying the summer and, especially, the rain that has appeared in some parts of the state.

Note that I am not able to send my blog and lists directly to you as I did for over 10 years. You can access them by reading my weekly blog and downloading my lists at https://audreysnetwork.wordpress.com/

Audrey